FTXH · First Trust Nasdaq Pharmaceuticals ETF ETF
First Trust Exchange-Traded Fund VI
$41.77
-1.05%
At close · Sep 4
Net assets $36,243,671
Holdings51
1 month
+5.68%
Year to date
+27.35%
52-week range
$27.30–$42.87
30-session avg volume
157,982
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000053945
- Report date
- Jun 30, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings53.06%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.90%
STIV0.10%
Country allocation
US95.59%
IE3.84%
BM0.57%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| ELI LILLY & COMPANY | LLY | $2,815,062 | 7.77% |
| ABBVIE INC | ABBV | $2,677,450 | 7.39% |
| MERCK & COMPANY INC | MRK | $2,562,547 | 7.07% |
| JOHNSON & JOHNSON | JNJ | $2,524,208 | 6.96% |
| BRISTOL-MYERS SQUIBB COMPANY | BMY | $2,281,176 | 6.29% |
| BIOGEN INC | BIIB | $1,390,562 | 3.84% |
| VIATRIS INC | VTRS | $1,313,181 | 3.62% |
| CARDINAL HEALTH INC | CAH | $1,279,498 | 3.53% |
| VERTEX PHARMACEUTICALS INC | VRTX | $1,234,374 | 3.41% |
| AMGEN INC | AMGN | $1,151,904 | 3.18% |
| PFIZER INC | PFE | $1,075,220 | 2.97% |
| GILEAD SCIENCES INC | GILD | $1,047,232 | 2.89% |
| UNITED THERAPEUTICS CORP | UTHR | $987,214 | 2.72% |
| REGENERON PHARMACEUTICALS INC | REGN | $984,570 | 2.72% |
| JAZZ PHARMACEUTICALS PLC | 000000000 | $901,469 | 2.49% |
| INCYTE CORP | INCY | $866,977 | 2.39% |
| ILLUMINA INC | ILMN | $718,793 | 1.98% |
| ZOETIS INC | ZTS | $676,706 | 1.87% |
| EXELIXIS INC | EXEL | $625,062 | 1.72% |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | CRL | $539,080 | 1.49% |
| MEDPACE HOLDINGS INC | MEDP | $511,584 | 1.41% |
| PTC THERAPEUTICS INC | PTCT | $496,843 | 1.37% |
| NEUROCRINE BIOSCIENCES INC | NBIX | $495,324 | 1.37% |
| ALKERMES PLC | 000000000 | $490,732 | 1.35% |
| HALOZYME THERAPEUTICS INC | HALO | $437,764 | 1.21% |
| BIOMARIN PHARMACEUTICAL INC | BMRN | $404,030 | 1.11% |
| TWIST BIOSCIENCE CORP | TWST | $372,323 | 1.03% |
| SPYRE THERAPEUTICS INC | SYRE | $350,503 | 0.97% |
| TRAVERE THERAPEUTICS INC | TVTX | $323,817 | 0.89% |
| TG THERAPEUTICS INC | TGTX | $310,026 | 0.86% |
| ELANCO ANIMAL HEALTH INC | ELAN | $300,488 | 0.83% |
| 10X GENOMICS INC | TXG | $282,451 | 0.78% |
| GUARDANT HEALTH INC | GH | $271,254 | 0.75% |
| LIGAND PHARMACEUTICALS INC | LGND | $270,573 | 0.75% |
| ARCUS BIOSCIENCES INC | RCUS | $256,999 | 0.71% |
| AMNEAL PHARMACEUTICALS INC | AMRX | $251,185 | 0.69% |
| ARROWHEAD PHARMACEUTICALS INC | ARWR | $237,846 | 0.66% |
| CATALYST PHARMACEUTICALS INC | 14888U101 | $231,231 | 0.64% |
| KRYSTAL BIOTECH INC | KRYS | $228,949 | 0.63% |
| PROTAGONIST THERAPEUTICS INC | PTGX | $226,038 | 0.62% |
| MODERNA INC | MRNA | $221,995 | 0.61% |
| MIRUM PHARMACEUTICALS INC | MIRM | $215,409 | 0.59% |
| KYMERA THERAPEUTICS INC | KYMR | $213,172 | 0.59% |
| ROIVANT SCIENCES LTD | 000000000 | $207,669 | 0.57% |
| ACADIA PHARMACEUTICALS INC | ACAD | $174,924 | 0.48% |
| IONIS PHARMACEUTICALS INC | IONS | $165,954 | 0.46% |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | $165,081 | 0.46% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $153,525 | 0.42% |
| SUPERNUS PHARMACEUTICALS INC | SUPN | $144,321 | 0.40% |
| TARSUS PHARMACEUTICALS INC | TARS | $141,552 | 0.39% |